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A B S T R A C T
Objective: The Trust in Oncologist Scale (TiOS) was recently developed and validated in The Netherlands
to assess cancer patients’ trust in their oncologist. In this study, we translated and further validated the
scale amongst English-speaking Australian cancer patients, to establish cross-cultural validity.
Methods: The translated 18-item scale was administered to cancer patients (n = 175) from three Sydney
hospitals. In addition to trust, we assessed patients’ satisfaction, trust in health care, and background
characteristics. Dimensionality, internal consistency, and construct validity of the translated scale were
assessed.
Results: Psychometric properties of all items were acceptable. Trust scores were very high. Factor
analyses indicated one-dimensionality of the scale. Internal consistency was strong. Moderate to high
correlations were found between trust (TiOS) and its known correlates, i.e., satisfaction, number of
previous consultations with the oncologist, and trust in health care, indicating good construct validity.
Conclusion: Trust is highly coherent, suggesting that cancer patients do not distinguish between
separate dimensions of trust. Future research could clarify if trust is equally strong and one-dimensional
among speciﬁc groups of cancer patients.
Practice implications: Both the English and the Dutch Trust in Oncologist Scales appear suitable for
assessing cancer patients’ trust reliably and validly.
 2012 Elsevier Ireland Ltd. 
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Cancer patients are confronted with a life-threatening diagnosis
and face difﬁcult and life-altering treatment decisions. Many
patients experience distress, uncertainty and vulnerability [1]. A
trusting relationship with the oncologist can alleviate patients’
burden, increase involvement in decision-making and reduce the
inclination to request a second opinion [2–5]. Hence, trust in the
oncologist is important. However, since not much empirical
research has shed light on why and how cancer patients’ trust
their oncologist [6], we know little about the realization, strength,
predictors, and consequences of cancer patients’ trust.
To gain a better understanding of patients’ trust, one ﬁrst needs to
be able to assess it. The only instruments available to date were* Corresponding author at: Academic Medical Center, University of Amsterdam,
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Open access under the Elsevier OA license. developed in the primary care setting [2,7,8]. The most recent of
these, Hall et al.’s Physician Trust Scale [2], has been validated most
extensively [9]. However, this scale might not be fully applicable to
cancer patients because of the speciﬁc nature of the oncology setting.
We therefore recently developed an oncology-speciﬁc trust
measuring instrument in Dutch, the Trust in Oncologist Scale
(TiOS), and established its reliability and validity among Dutch
cancer patients [10].
The suitability of the TiOS for English-speaking cancer patients
has not yet been conﬁrmed. To allow for cross-cultural compari-
son, we validated an English translation of the TiOS among English-
speaking Australian cancer patients. Dimensionality, construct
validity, and reliability were assessed.
2. Methods
2.1. Construction of the TiOS in Dutch
The TiOS was based on Hall et al.’s 10-item ‘Physician Trust
Scale’ [2], and on qualitative data regarding cancer patients’
Table 1
Demographic, health and relationship characteristics of the sample (n = 175).
Age (n = 174) Median Range
62 21–88
N %
Gender (n = 175)
Male 76 43
Female 99 57
Educational level (n = 175)
None/primary school 14 8
Secondary/lower level vocational school 103 59
College/university 58 33
Ethnicity (n = 175)
Australian 144 82
Other 31 18
Religious (n = 173)
Yes 146 84
No 27 16
Time since diagnosis (n = 173)
<1 month 1 1
1–6 months 18 10
6–24 months 49 28
>24 months 105 61
Specialist about whom reported (n = 175)
Radiation oncologist 38 22
Medical oncologist 137 78
Self-reported cancer site (n = 175)
Breast 60 34
Genitourinary 49 28
Gastrointestinal 26 15
Gynecologic 10 6
Lung 9 5
Bone 5 3
Skin 5 3
Other 11 6
Number of consultations with present oncologist (n = 175)
<3 consultations 15 9
3–5 consultations 26 15
6–10 consultations 43 25
11–15 consultations 35 20
>15 consultations 56 32
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patients’ trust was constructed, encompassing competence, ﬁdelity,
conﬁdentiality, honesty, and caring. Appropriate items for all
dimensions were collected from the ‘Physician Trust Scale’ and
related scales [2,7,12,13], or newly constructed. The resulting 33
candidate-items were pilot-tested. During questionnaire valida-
tion, the ‘Conﬁdentiality’ dimension was removed. The ﬁnal 18-
item scale comprised four dimensions, i.e., (1) Fidelity; the
oncologist’s pursuit of the patients’ interests, (2) Competence;
the oncologist’s medical skills, (3) Honesty; telling the truth and
avoiding intentional falsehoods, and (4) Caring; the oncologist’s
involvement, sympathy and devotion of attention to the patient.
For a full description of the construction of the TiOS, see Hillen et al.
[10]. The TiOS was translated into English following a forward-
backward procedure [14].
2.2. Validity testing
2.2.1. Patients and procedure
Adult, English-speaking cancer patients in treatment or follow-
up were recruited from four Medical Oncology and Radiation
Oncology departments of three hospitals in the Sydney area.
Dependent on department policies, patients were either
approached face-to-face by a researcher (location 1), approached
by their physician (locations 2 and 4) or directly mailed the
questionnaire (location 3). All patients received an introductory
letter and the questionnaire, leaving open the possibility to refuse
participation. Ethics approval was obtained from the University of
Sydney and Area Health Service Ethics Committees linked to the
participating cancer centres.
2.2.2. Instruments
All 18 items of the TiOS consist of a proposition in the third
person singular, with a 5-point Likert answering scale (‘strongly
disagree’ (1) to ‘strongly agree’ (5)). Three items are negatively
phrased. Mean trust (range 1–5) is calculated by averaging the
responses.
Socio-demographics (gender, age, marital status, education
level, ethnicity, mother tongue and religion) and disease char-
acteristics (time since diagnosis, cancer site and treatments
undergone, number of previous consultations with the present
oncologist) were assessed. Satisfaction with the oncologist was
assessed with the 5-item Patient Satisfaction Questionnaire (PSQ)
[15]. An additional item asked whether patients would recom-
mend their oncologist to their friends. Physical and mental Health
Related Quality of Life (HRQOL) were measured with the 12-item
short form health survey (SF-12) [16]. Finally, one item asked
patients how much trust they had in the Australian health care
system.
2.2.3. Analyses
For missing values, we used expectation maximization [17].
Using conﬁrmatory factor analysis (CFA), we tested our 4-
dimensional model ﬁrst, then a uni-dimensional representation
of trust. A good model ﬁt would be indicated by non-signiﬁcant x2,
and Root Mean Square Error of Approximation (RMSEA) < .06 [18].
As in the Dutch sample, we expected uni-dimensionality, but also a
reasonably good ﬁt of our 4-dimensional model. We calculated
internal consistencies (Cronbach’s a), inter-item correlations and
item-scale correlations for the TiOS. Construct validity was
assessed by calculating Spearman’s correlations between trust
(TiOS) and its known correlates: satisfaction, trust in health care,
and number of previous consultations with the oncologist. We
expected that high trust levels would be strongly associated with
high satisfaction, and moderately with strong trust in health care
and a larger number of previous consultations [2,3,19,20].Exploratory, we assessed correlations between trust and patients’
HRQOL, socio-demographics and disease characteristics. No
hypotheses were speciﬁed with regard to exploratory analyses.
Analyses were performed using SPSS 16 [21], and Lisrel 8.5 [22].
3. Results
In total, 177 questionnaires were returned (response rate 70%,
range 56–84% for the different locations). Data from two
participants were excluded because of more than 25% missing
data. Socio-demographic characteristics of the sample are shown
in Table 1. All items, including their psychometric properties, are
displayed in Table 2. Skewness was below 2 for all items, and item-
scale correlations were >.3. Mean trust over all 18 items was 4.47
(SD = .50, range 2.50–5.00). The theoretically driven 4-factor
model failed to converge in CFA. This was probably due to
collinearity, as indicated by between-item correlations as strong as
.8. Moreover, even when collapsing response categories 1 and 2,
the distribution of trust scores over response categories remained
uneven, including empty or near-empty cells. A one-dimensional
model resulted in an acceptable model ﬁt (SBx2 ð137Þ ¼ 200:73,
p < .01, and RMSEA = .05) [23]. Standardized item loadings on this
factor were strong (mean: .80, range: .58–.91) [23]. Post hoc
exploratory factor analysis, to check if a one-dimensional model ﬁt
would be conﬁrmed when no assumptions were made about the
data, further established the one-dimensionality of the TiOS.
Very strong internal consistency of the TiOS was suggested by
Cronbach’s a of .94 [24]. Item-scale correlations were acceptable
Table 2
Overview of all items of the TiOS, including their dimension, mean, standard deviation, skewness, and item-scale correlation.
Item Content Dimension Mb SD Skewness Item-scale
correlation
1 Your doctor is very careful and precise Competence 4.58 0.60 1.4 0.73
2 Your doctor is totally honest in telling you about all the different treatment
options available for your condition
Honesty 4.61 0.60 1.6 0.71
3 Your doctor always gives you honest information about your prospects Honesty 4.58 0.56 1.1 0.67
4 Your doctor strongly cares about your health Fidelity 4.58 0.59 1.1 0.77
5 Your doctor always tells you everything you want to know about your illness Fidelity 4.50 0.65 1.5 0.65
6 You think your doctor can handle any medical situation, even a very serious one Competence 4.50 0.68 1.2 0.69
7 Your doctor always takes his/her time with you Caring 4.57 0.67 1.8 0.68
8 Your doctor explains everything so that you can consent to medical decisions Fidelity 4.58 0.56 0.9 0.69
9 Sometimes you worry that your doctor’s medical decisions are wronga Competence 4.32 0.90 1.5 0.57
10 Your doctor only thinks about what is best for you Fidelity 4.50 0.65 1.2 0.79
11 Sometimes your doctor does not pay full attention to what you are trying to tell him/hera Competence 4.33 0.89 1.5 0.58
12 Your doctor would always tell you the truth about your health, even if there was bad news Honesty 4.50 0.67 1.9 0.56
13 You have doubts whether your doctor really cares about you as a persona Caring 4.32 1.02 1.9 0.43
14 Your doctor listens with care and concern to all the problems you have Caring 4.47 0.66 1.2 0.79
15 Your doctor will do whatever it takes to get you all the care you need Fidelity 4.49 0.70 1.4 0.81
16 Your doctor is available for you whenever you need him/her Caring 4.03 0.96 1.1 0.59
17 You have no worries about putting your life in your doctor’s hands Global item 4.40 0.80 1.4 0.66
18 All in all, you have complete trust in your doctor Global item 4.57 0.63 1.3 0.76
a Reverse-scored items.
b Five-point likert scale: 1 = totally disagree, 2 = disagree, 3 = as much agree as disagree, 4 = agree, 5 = strongly agree.
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.8. As expected, mean scores on the TiOS correlated signiﬁcantly
with known correlates of trust, i.e., satisfaction with the oncologist
(PSQ: rs = .62), willingness to recommend the oncologist to others
(rs = .59), number of previous visits with the oncologist (rs = .21)
and trust in health care (rs = .33). All correlations in the exploratory
analyses were non-signiﬁcant.
4. Discussion and conclusion
4.1. Discussion
In this study, the English version of the 18-item Trust in
Oncologist Scale (TiOS) was validated. Mean trust scores were
invariably high. Strong internal consistency, inter-item correla-
tions and item-scale correlations suggest sufﬁcient reliability.
Construct validity was conﬁrmed by strong correlations of TiOS
scores with satisfaction and moderate correlations with number of
previous visits with the oncologist and with trust in health care.
Importantly, we found TiOS scores to be one-dimensional,
indicating that these patients do not distinguish between different
aspects of trust, i.e., competence, ﬁdelity, honesty, and caring.
Although this distinction was slightly stronger among Dutch
patients, we still concluded that trust was best considered as a one-
dimensional construct. The present ﬁndings conﬁrm this sugges-
tion of one-dimensionality. The even weaker distinction between
dimensions of trust by Australian patients could reﬂect a more
homogeneous composition of this sample. Even though mean trust
was equally high in both samples, the Australian data lack
sufﬁcient variation in trust scores. Very few patients reported weak
trust in their oncologist. This lack of variation may be due to
Medical Ethical Committee regulations, prohibiting the random
and direct approach of patients by mail as employed in the Dutch
sample. Recruitment via the participating oncologists may have
resulted in selection bias towards including only strongly trusting
patients.
Our repeated ﬁnding of one-dimensionality of patients’ trust
conﬁrms earlier quantitative ﬁndings [2,3,7]. However, it contra-
dicts qualitative ﬁndings suggesting that cancer patients do
distinguish between dimensions of trust [11,26]. This apparent
discrepancy deserves further research attention. As yet, it appears
difﬁcult to quantitatively expose patients’ possible distinctionbetween trust dimensions. Further validation among speciﬁc
groups of cancer patients with likely more varying levels of trust
should be conducted, e.g., among second opinion patients,
immigrants, or patients in palliative care, to investigate if the
TiOS is responsive to more pronounced dimensionality and varying
trust levels.
4.2. Conclusion
The current results contribute to research on cancer patients’
trust in their oncologist. Use of the TiOS allows further expansion
of this ﬁeld of study, resulting in better insight into the nature,
predictors, and consequences of cancer patients’ trust. Conﬁdence
in the cross-cultural validity of the TiOS enables its use in different
countries, allowing direct comparisons between patients’ trust
levels internationally. Ultimately, this could improve patient care.
4.3. Practice implications
Our ﬁndings suggest that the English translation of the Trust in
Oncologist Scale is suitable for use among English-speaking cancer
patients in Australia and other countries with similarly organized
health care systems. For the present we suggest that when
applying the TiOS, a single score can be used. However, for a more
reﬁned understanding of patients’ trust, one might test whether
patients in a speciﬁc sample distinguish different dimensions of
trust.
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